You searched for point-of-care | Page 40 of 256

FloBio Gets FDA Breakthrough Device Designation for Bleeding Risk Diagnostic Test

FloBio announced that the U.S. FDA has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test.

For Strata Oncology, clinical diagnostics is critical for the move to a precision medicine model. It’s doing so with its Strata Select test.

Posted by Andy Lundin | Sep 28, 2023 | Disease States |

Anbio has developed an effective method using real-time polymerase chain reaction (RT-PCR) for the early detection of Parkinson’s Disease.

PCR Biosystems’ new range of Bst polymerase reagents offers greater sensitivity and specificity in all isothermal amplification applications.

Posted by Chris Wolski | Sep 26, 2023 | Sepsis |

Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.